Sign inJoin waitlistJoin the waitlist

Howard Safran

Division Director, Hematology-Oncology · Alpert Medical School

Credentials: · · · ·

History

Hematology Oncology Division · Rhode Island Hospital/Brown University Health
Present
Alpert Medical School
Present

Hematology and Medical Oncology
1990–1993
Boston Medical Center
1987–1990
Boston University School of Medicine
1983–1987

Research

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre,…
The Lancet · 2014 · 1,729 citations
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer
Journal of Clinical Oncology · 2004 · 649 citations
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial
JAMA · 2008 · 605 citations

Thomas DiPetrillo
33 papers
Wafik El-Deiry
19 papers
Wallace Akerley
16 papers
William Regine
16 papers
RA
Ross Abrams
15 papers
Benedito Carneiro
14 papers
Paul Akerman
14 papers · 1 as a fellow
HW
Harold Wanebo
13 papers
Christopher Crane
11 papers
Christopher Willett
11 papers
DI
David Iannitti
11 papers · 1 as a resident
John Hoffman
11 papers

Grants

Taxol with Radiation for Pancreatic and Gastric Cancer
National Cancer Institute · R03
Contact PI · $147K · Miriam Hospital
1996–1999
Biomedical Research Support
National Center for Research Resources · S07
Project lead · Boston University Medical Center Hosp

Clinical trials

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
Principal investigator · Active not recruiting · Phase 2
Brown University
2023–2026
Biomarkers For Immune Checkpoint Inhibitors
Principal investigator · Completed
Rhode Island Hospital
2016–2024
FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Principal investigator · Completed · Phase 2
Brown University
2016–2022
Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease
Principal investigator · Terminated · Phase 2
howard safran
2016–2018